TrialBMJ case reports2012

Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature review.

Jennifer Croke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.